Pamela Furman Forrest is a partner in King & Spalding’s FDA & Life Sciences Practice Group. Ms. Forrest joined the firm in 2007, bringing with her more than 12 years of experience in advising clients on a broad range of FDA regulatory issues. Her practice focuses on FDA medical device matters, including premarket notification, premarket approval, product recalls, Medical Device Reporting (MDR), Quality System Regulation (QSR) compliance, establishment registration and device listing, labeling and promotion, reclassification, import/export issues and Investigational Device Exemption (IDE) requirements. In addition, Ms. Forrest frequently assists medical device manufacturers, investment banks, and private equity funds with due diligence evaluations of FDA-regulated companies.
Ms. Forrest has written and spoken extensively on various aspects of FDA regulation of medical devices, and has testified before several State legislative committees regarding medical device legal and regulatory issues.
Ms. Forrest graduated summa cum laude, Phi Beta Kappa, from Yale University in 1988, with a Bachelor of Arts in political science. She received her law degree from Stanford University in 1994. Ms. Forrest currently serves on the Advisory Board of BNA’s Medical Devices Law & Industry Report.